[1] Asahina A,Akazaki S,Nakagawa H,et al.Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris.JInvestDermatol,1991,97:254-258. [2] Ikaheimo I,Silvennoinen-Kassinen S,Karvonen J,et al.Alanine at position 73 of HLA-C associated with psoriasis vulgaris in Finland.BrJDermatol,1994,131:257-259. [3] Rani R,Narayan R,Fernandez-Vina MA,et al.Role of HLA-B and C alleles in development of psoriasis in patients from North India.TissueAntigens,1998,51:618-622. [4] Alvarez L,Guanabens N,Peris P,et al.Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget′s disease.J BoneMinerRes,1995,10:458-465. [5] 赵桐茂主编,HLA分型原理及应用,上海:上海科学技术出版社,1984.209-210 [6] Bjorkman PJ,Saper MA,Samraoui B,et al.Structure of the human class I histocompatibility antigen,HLA-A2.Nature,1987,329:506-512. [7] Jennie C,Lawrence R,Karen J,et al.Persistence of T-cell clones in psoriatic lesions.ArchDermatol,1997,133:703-708 [8] Jennie C,Lawrence R,Karen J,et al.CD8+ Tcells in psoriasis lesions preferentially use T-cell receptor Vβ3 and/or Vβ13.1 genes.Proc Natl AcadSciUSA,1994,91:9282-9286. [9] Vallat VP,Gilleaudeau P,Battat L,et al.PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis,a possible cellular basis for remittive therapy.JExpMed,1994,180:283-296. [10] Gottlieb SL,Gilleaudeau P,Johnson R,et al.Response of psoriasis to a lymphocyte selective toxin (DAB389 IL-2) suggests a primary immune,but not keratinocyte pathogenic basis.NatMed,1995,1:442-447. |